Sumitomo Pharma Shares Drop After Stem-Therapy Backing
Sumitomo Pharma Co. shares declined after a Japanese government panel endorsed a conditional approval for its regenerative therapy, built on technology pioneered by a Nobel Prize laureate.
By Kanoko Matsuyama · Bloomberg Markets
Sumitomo Pharma Co. shares declined after a Japanese government panel endorsed a conditional approval for its regenerative therapy, built on technology pioneered by a Nobel Prize laureate.